INVESTMENT FOCUS

Industry Focus

We focus on life science companies that can provide exceptional value to patients, clinicians or providers. Guided by our experience as industry professionals and venture capital investors, we invest in medical device, biotechnology and diagnostic companies developing breakthrough products and therapies. We do not consider healthcare information technology or service opportunities.

Stage and Geographic focus:

By virtue of our regional presence and capital funding, Triathlon is one of the leading sources of early-stage life science investment capital in the Midwest. We make investments in early-stage opportunities, typically when there are only a few employees and great idea. We look for a solid business plan with a unique solution to an unmet medical need, and experienced management. For these early stage opportunities we invest exclusively in the Midwest.

We also invest nationally in mid- to later-stage life science companies that meet the same strategic, technical and business criteria. However these companies should already have a seasoned management team in place that is effectively executing the business vision, a clear proof of clinical efficacy, and an existing knowledgeable, committed, and well-capitalized investor group.